Aug 2026· Biochemical Pharmacology· Vol 254, pp.
118401
· 0 citations· 57 references
Medicine
TL;DR
Findings indicate that integrin αVβ3-associated FAK and RhoA/ROCK signaling contribute to focal adhesion remodeling and fibroblast activation during renal fibrosis, suggesting that this signaling network may represent a potential therapeutic target for renal fibrosis.
Abstract
Renal fibrosis is a progressive pathological process underlying chronic kidney disease (CKD), characterized by persistent fibroblast activation and excessive extracellular matrix accumulation. Although integrin-dependent focal adhesion signaling has been implicated in tissue fibrosis, its role in renal fibroblast activation remains incompletely understood. In this study, publicly available single-cell and bulk transcriptomic datasets were integrated to characterize fibroblast-associated signaling alterations in fibrotic kidneys. Experimental validation was subsequently performed in a 5/6 nephrectomy rat model and TGF-β1-stimulated NRK-49F cells. Bioinformatic analyses revealed enrichment of extracellular matrix organization, focal adhesion, and cytoskeleton-related pathways in activated fibroblasts. Increased integrin αVβ3 expression and enhanced focal adhesion signaling were further confirmed in fibrotic renal tissues. Pharmacological inhibition of integrin αVβ3 with cyclo-RGDfK attenuated fibroblast adhesion, migration, and extracellular matrix production, accompanied by reduced FAK phosphorylation and RhoA expression. Furthermore, inhibition of FAK with PF-573228 impaired focal adhesion remodeling, disrupted F-actin stress fiber organization, and reduced fibroblast activation and extracellular matrix production. Pharmacological inhibition of ROCK with Y-27632 reduced MYPT1 phosphorylation, accompanied by impaired F-actin stress fiber organization and decreased fibroblast activation, supporting a functional role of ROCK signaling in focal adhesion remodeling and fibroblast activation. Collectively, these findings indicate that integrin αVβ3-associated FAK and RhoA/ROCK signaling contribute to focal adhesion remodeling and fibroblast activation during renal fibrosis, suggesting that this signaling network may represent a potential therapeutic target for renal fibrosis.
Renal fibrosis represents the final common pathway in the progression of chronic kidney disease (CKD), characterized by excessive deposition of extracellular matrix (ECM) and progressive disruption of renal architecture. To date, no approved therapy can fully reverse established or advanced fibrosis. This review compre...
Yang-Yang Cai, Qian Wu, Fang Dou et al.· Experimental and molecular p...· 0 citations
Platelets are a major reservoir of bioactive mediators, including growth factors such as transforming growth factor β1 (TGF-β1), that regulate vascular repair and tissue remodeling. Beyond these classical functions, platelets also participate in inflammatory hemostasis through activation pathways that differ from those...
Raphaël Martos, J. Salfati, Carlotta Turnaturi et al.· Blood Advances· 0 citations
It is suggested that DSP may function as a regulator of alveolar epithelial homeostasis and extracellular matrix remodeling in an in vitro epithelial model, and a candidate pathway that may contribute to ECM dysregulation in IPF is identified.
Cardiac fibrosis is a major pathological feature of several cardiovascular diseases and is characterized by excessive extracellular matrix deposition, leading to ventricular stiffening, impaired cardiac function, and ultimately heart failure. Despite its substantial clinical burden, therapies specifically targeting the...
Darío Cañate Cañate, P. Araos, Samir Bolívar González· Current Issues in Molecular...· 0 citations
Acute respiratory distress syndrome (ARDS) is characterized by impaired alveolar-capillary permeability and pulmonary edema. Alveolar fluid clearance (AFC) is strongly associated with patient prognosis. This study aimed to investigate whether chronic alcohol consumption affects sodium channel regulation in ARDS via...
Xue Dai, Xue-Ling Liu, Mei-Jun Liu et al.· Frontiers in Pharmacology· 0 citations
GARP-mediated release of active TGF-β is identified as a critical step in sustaining fibroblast activation during kidney fibrosis and highlight GARP as a promising therapeutic target for CKD.